Mace Rothenberg (Pfizer)

Mace Rothen­berg starts the year by step­ping out of his top job in Pfiz­er R&D — as Stan­ford’s Ai­da Habtezion steps in

There’s a chang­ing of the guard un­der­way in the se­nior ranks of Pfiz­er’s R&D team.

Chief med­ical of­fi­cer Mace Rothen­berg, who helped lead the phar­ma gi­ant to 6 new drug ap­provals in the last 2 years, is step­ping aside from his high pro­file perch and hand­ing the job to Ai­da Habtezion, a physi­cian sci­en­tist who’s been do­ing re­search on leuko­cytes at Stan­ford.

Rothen­berg put out the word on so­cial me­dia Mon­day, though he didn’t say just what he had on his mind for the next chap­ter in his ca­reer. He told me via LinkedIn, though, that he’s most in­ter­est­ed in find­ing some key board po­si­tions where he can be most use­ful.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.